Document Detail


Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
MedLine Citation:
PMID:  12796787     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We reviewed the results of the Dutch paediatric bone marrow transplant (BMT) program for children receiving HLA-identical BMT for beta-thalassaemia major over an 18-year period. In all, 19 patients underwent a total of 21 transplants in our treatment centre between July 1984 and February 2002. Eight females (age 0.3-12 years; median 5 years) and 11 males (age 0.8-18 years; median 6 years) were included. Information, prospectively collected, included molecular defects, donor genotype, beta/alpha-globin expression rates, serum ferritin levels, hepato-splenomegaly, chelation history, virology screening, liver pathology together with post-transplant outcome inclusive of leucocyte chimerism. In total, 11 patients received standard busulphan/cyclophosphamide (Bu/Cy) conditioning, with or without ATG. Stable engraftment was seen in 5/11 with late rejection occurring in six patients. Of these, two children underwent a second successful SCT. For this group, overall event-free survival (EFS) and disease-free survival (DFS) were 90 (10/11) and 64% (7/11), respectively. The probability of rejection was 55%. Subsequent addition of melphalan to the conditioning regimen resulted in long-term stable engraftment in all patients with an EFS/DFS for this group of 90% (9/10). Treatment-related mortality, irrespective of conditioning, was low at 5% (1/19 patients). Veno-occlusive disease (VOD) occurred in 19% (4/21 transplants) and acute GvHD in 19% (4/21 transplants). Post-BMT beta/alpha synthetic ratio measurement monitored donor erythroid engraftment and predicted rejection with a return to transfusion dependency. Maintained full donor chimerism is indicative of stable engraftment both for leucocyte and erythroid lineages, whereas mixed donor chimerism is not. Our results emphasise the importance of the conditioning regimen and post-transplant chimerism surveillance predictive of rejection or long-term stable engraftment.
Authors:
L M Ball; A C Lankester; P C Giordano; M H van Weel; C L Harteveld; R G M Bredius; F J Smiers; R M Egeler; J M J J Vossen
Related Documents :
15288357 - Consideration of rituximab for fibrodysplasia ossificans progressiva.
2193017 - Immune recovery after bone marrow transplantation.
17300507 - Polymyositis--an unusual presentation of cgvhd in children.
3518097 - The incidence of interstitial pneumonitis: comparison of total body irradiation schedul...
10612477 - Current and future prospects for xenotransplantation.
16518627 - Recurrence of proteinuria following renal transplantation in congenital nephrotic syndr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Bone marrow transplantation     Volume:  31     ISSN:  0268-3369     ISO Abbreviation:  Bone Marrow Transplant.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-06-10     Completed Date:  2004-03-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8702459     Medline TA:  Bone Marrow Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  1081-7     Citation Subset:  IM    
Affiliation:
The Department of Paediatrics, Leiden University Medical Centre, Leiden, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Bone Marrow Transplantation* / adverse effects
Child
Child, Preschool
Chimera
Disease-Free Survival
Female
Graft Rejection
Graft Survival
Graft vs Host Disease / etiology
Homozygote
Humans
Infant
Male
Netherlands
Transplantation Conditioning / adverse effects
Transplantation, Homologous
beta-Thalassemia / genetics,  therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonm...
Next Document:  Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients wi...